Impact Of Digital Marketing In Selling Over-The-Counter (Otc) Pharmaceutical Products In India: Emerging Trends, Challenges, And The Road Ahead
DOI:
https://doi.org/10.66635/q994eq51Keywords:
OTC medicines, Pharmaceutical marketing, Digital marketing, India, Consumer behavior, Social media marketingAbstract
Purpose
India’s pharmaceutical sector is expanding rapidly, with Over-the-Counter (OTC) products playing a growing role in healthcare access. This paper examines how digital marketing is shaping the promotion, awareness, and use of OTC medicines in India.
Design/methodology/approach
Digital platforms such as social media, e-commerce, influencer marketing, search engines, and health apps are evaluated. Emerging trends—including AI personalization, regional language content, telehealth integration, and gamification—are discussed alongside challenges such as regulatory gaps, ethical issues, misinformation, digital literacy, and the prescription–OTC divide. A Google survey of 92 participants provided insights into consumer behavior, trust, and responses to digital promotions.
Findings
Digital marketing has broadened awareness and supported consumer decision-making, but trust remains anchored in pharmacists and doctors. Survey results show digital strategies influence purchase intent, yet credibility and transparency are critical for lasting confidence.
Social implications
Strengthening health literacy, ensuring equitable access, and promoting ethical digital practices are essential to protect consumers and enhance public health outcomes.
Originality/value
By combining secondary analysis with primary survey data, this study offers a comprehensive perspective on India’s OTC market. It highlights the need for responsible, consumer-centric digital innovation that balances business growth with public wellbeing.
References
1. Chautrakarn S, Khumros W, Phutrakool P. Self-medication with over-the-counter medicines among the working age population in metropolitan areas of Thailand. Frontiers in pharmacology. 2021;12:726643.
2. Bekele SA, Argaw MD, Yalew AW. Magnitude and factors associated with self-medication practices among university students: the case of Arsi University, College of Health Science, Asella, Ethiopia: cross-sectional survey based study. Open Access Library Journal. 2016;3(6):1-15.
3. Shaghaghi A, Asadi M, Allahverdipour H. Predictors of self-medication behavior: a systematic review. Iranian journal of public health. 2014;43(2):136.
4. Kathuria R. The Digital Connectivity and Development: The case of India. South Asian Economic Development in the Era of Global Turbulence: Routledge; 2025. p. 136-42.
5. Yadav OP, Teotia R, Baliyan R. Digital Transformation and Consumer Behavior: A Marketing Perspective. Digital Economy of India. 2024;12(2):41.
6. Wake TS, Shambharkar DA, Bijwar RS, Barde LN. Different marketing strategy for OTC and branded drug: A Systematic Review. World Journal of Pharmaceutical Research. 2025;14(6):339-63.
7. Almeman A. The digital transformation in pharmacy: embracing online platforms and the cosmeceutical paradigm shift. Journal of Health, Population and Nutrition. 2024;43(1):60.
8. Group I. India Over The Counter (OTC) Drugs Market Size, Share, Trends and Forecast by Product Type, Route of Administration, Dosage Form, Distribution Channel, and Region, 2025-2033. December 2024.
9. Chawla A. How much do Indian households spend on healthcare every month. Retrieved from The Wirewebsite: https://thewire in/health/how-much-do-indian-householdsspend-on-healthcare-every-month. 2023.
10. Parija PP, Tiwari P, Sharma P, Saha SK. Determinants of online health information-seeking behavior: A cross-sectional survey among residents of an urban settlement in Delhi. Journal of education and health promotion. 2020;9(1):344.
11. Golinelli D, Boetto E, Carullo G, Nuzzolese AG, Landini MP, Fantini MP. Adoption of digital technologies in health care during the COVID-19 pandemic: systematic review of early scientific literature. Journal of medical Internet research. 2020;22(11):e22280.
12. Amankwah-Amoah J, Khan Z, Wood G, Knight G. COVID-19 and digitalization: The great acceleration. Journal of business research. 2021;136:602-11.
13. Singh K, Rana P, Sandhu R. E Pharmacy. 2022.
14. Atkins K, Kennedy CE, Yeh PT, Narasimhan M. Over-the-counter provision of emergency contraceptive pills: a systematic review. BMJ open. 2022;12(3):e054122.
15. Kahn BE. The shopping revolution, updated and expanded edition: how retailers succeed in an era of endless disruption accelerated by COVID-19: University of Pennsylvania Press; 2021.
16. Zairis A, Zairis G, editors. Digital innovation: The challenges of a game-changer. European Conference on Innovation and Entrepreneurship; 2022: Academic Conferences International Limited.
17. Abomusallam AS. Digital customer engagement: how can pharmaceutical organizations create better value? : University of Warwick; 2023.
18. Deshpande A. A review on impact of e-pharmacy on pharmacy and social sector. Journal of Pharma Innovation. 2023;3(1):7-15.
19. Rahaman S, Mohammed S, Manchanda T, Mahadik R, editors. E-Pharm assist: The future approach for dispensing medicines in smart cities. 2019 International Conference on Digitization (ICD); 2019: IEEE.
20. Srivastava R. How Indian pharmaceutical companies are building global brands: The case of the Himalaya herbal brand. Thunderbird International Business Review. 2016;58(5):399-410.
21. Sabale¹ BY, Barbole KM, Barbole KM, Dhale CR. A Review: Current Scenario of Herbal Drug as Over-The-Counter Product. 2025.
22. Leaders eBook S, Sender AUAAS. Novartis, GSK, Bayer and Merck Become Movers in the OTC Market Total.
23. Mani S. Market leadership in India’s pharmaceutical industry: The case of CIPLA Limited. The Rise to Market Leadership: Edward Elgar Publishing; 2017. p. 99-123.
24. Sarangi P. Case Commentary on Sun Pharmaceutical Industries Ltd. v. Cipla Ltd., Appl. Nos. 1980, 1982 & 1983 of 2021. Indian JL & Legal Rsch. 2021;3:1.
25. Evangeline L, Mounica N, Reddy VS, Ngabhushanam M, Reddy DN, Bonthagarala B. Regulatory process and ethics for clinical trials in India (CDSCO). The Pharma Innovation. 2017;6(4, Part C):165.
26. Srinivasan S, Jesani A. Standing committee report on CDSCO: hard facts confirm an open secret. Indian Journal of Medical Ethics. 2012;9(3).
27. Sharma AK, Shrivastava TP, Singh MA, Ahuja J, Goyal RK. Regulations in India. Global Regulations of Medicinal, Pharmaceutical, and Food Products: CRC Press; 2024. p. 133-52.
28. Vyshnavi A, Roopa Bai R, Udaykumar Nidoni SH. Role of Advertising Standards Council of India (ASCI) in food & beverages industry: A review. 2024.
29. ALLADI M. Uniform code for pharmaceutical marketing practices (UCPMP) 2024. THE NATIONAL MEDICAL JOURNAL OF INDIA. 2024;37(3):173.
30. Bhattacharya N. Disparate Remedies: Making Medicines in Modern India: McGill-Queen’s University Press (mqup); 2023.
31. Krishna LT, Sinha S. Online pharmacies in India and 3 massive problems! competing competitions. 2024.
32. Deshmukh M, Tilak P, Deodhar M. E-pharmacy in india-An overview. 2022.
33. Awari MN, Suryawanshi P. A REVIEW ON E-PHARMACY IN INDIA–SWOT ANALYSIS. National Journal of Research In Marketing, Finance & HRM. 2021:100.
34. Alarsali N, Aghaei I. Effective determinants of consumer buying decision on OTC medications: Digital marketing, brand experience, and reference groups. BOHR International Journal of Computer Science. 2022;1(1):56-67.
35. Roblek V. Impact of internet and social media on organisational change of OTC medicines marketing management. International Journal of Electronic Marketing and Retailing. 2015;6(3):239-58.
36. Anis MS, Hassali MA. Pharmaceutical marketing of over-the-counter drugs in the current digital era: A review. Pharmaceutical Sciences Asia. 2022;49(2).
37. ARORA S, SHARMA S. THE IMPACT OF OVER THE COUNTER MEDICINE MEDICATION ON PUBLIC HEALTH.
38. Shalmont J, Darmawan GI, Dominica D. The Sale of Prescription Medicines Through E-Commerce Platform Without Prescription: Between Urgency And Compliance. Arena Hukum. 2024;17(1):19-42.
39. Bate R, Jin GZ, Mathur A. In whom we trust: the role of certification agencies in online drug markets. The BE Journal of Economic Analysis & Policy. 2014;14(1):111-50.
40. Sonawadekar MAA, Navale MSS, PA M, Salokhe DN, Sonawadekar MAA. Marketing Strategies for Medicinal Product of Prescribed and Non Prescribed Drug.
41. Khan A. Current Trends in the Development of Over-the-Counter Medications. American Journal of Pharmaceutics. 2024;5(6):24-34.
42. Maeckelberghe E, Zdunek K, Marceglia S, Farsides B, Rigby M. The ethical challenges of personalized digital health. Frontiers in Medicine. 2023;Volume 10 - 2023.
43. ΣΩΤΗΡΙΟΥ Α. Digital marketing during COVID-19 pandemic: The case of pharmaceutical products.
44. Patil DG, Pore AV, Dongare GD, Bais SK. A Review on Pharmaceutical Sales and Marketing. International Journal of Pharmacy and Herbal Technology. 2024;2(4):3040-51.
45. Söderström KR, Sundin O. Exploring the digital gray zone of online medicinal markets emerging from search. Journal of the Association for Information Science and Technology. 2024;75(13):1498-514.
46. Holmér GW, Gamage IH. Development of a data-driven marketing strategy for an online pharmacy. 2022.
47. Kolesnik Y. More Than Just Ads: Building Awareness and Engagement with AI-Driven Digital Marketing in a Regulated World. 2025.
48. Chaffey D, Smith PR. eMarketing eXcellence: Planning and optimizing your digital marketing: Routledge; 2013.
49. Tomar H, Krishnamoorthy B. Post-COVID Emergent trends in consumer buying behaviour for pharma-OTC Sector. NMIMS Mumbai. 2021:1-60.
50. Dingre S, Girbane V, Garudkar S, Todakari P, Borawake D, Deshmukh M. Integrating artificial intelligence in pharmaceutical marketing: Enhancing engagement and efficiency. 2025.
51. Unanah OV, Mbanugo OJ. Integration of AI into CRM for effective US healthcare and pharmaceutical marketing. World Journal of Advanced Research and Reviews. 2025;25(02):609-30.
52. Singh K, Singh S, Wadhwa S, Baghel DS. Integrating the AI-Driven Technologies Into Pharmaceutical Service Marketing. Integrating AI-Driven Technologies Into Service Marketing: IGI Global; 2024. p. 395-418.
53. Behl A, Dutta P, Sheorey PA, Rowley C. Changing Face of E-commerce in Asia: World Scientific; 2022.
54. Kim Y, Chae Y-G, Kim Y-C. “Doing community”: digital hyperlocal media as care. Digital Journalism. 2024;12(1):13-27.
55. Singh S, Gagal S, Chakladar A. A cross-sectional comparative study analyzing the quality of YouTube videos as a source of information for treatment of erectile dysfunction in English and Hindi language. Sexuality & Culture. 2024;28(4):1588-602.
56. Umair M. Hyperlocal Supply Chains for Quick Commerce: An Indian Perspective. Methods and Applications of Quick Commerce (Q-Commerce): IGI Global Scientific Publishing; 2026. p. 367-98.
57. North F, Uthke LD, Tulledge-Scheitel SM. Integration of e-consultations into the outpatient care process at a tertiary medical centre. Journal of telemedicine and telecare. 2014;20(4):221-9.
58. Shah M, Gole P. SUSTAINABILITY OF ONLINE PHARMACIES POST PANDEMIC. DIGITALIZATION.46.
59. Roncal-Belzunce V, Gutiérrez-Valencia M, Echeverría-Beistegui I, Martínez-Velilla N. Optipharm: Enhancing pharmacological management skills in healthcare students for geriatric care through gamified e-learning. International Journal of Medical Informatics. 2024;190:105535.
60. Krishnadas R, Renganathan R. Factors Determining the Customers’ Intention to Purchase OTC Products through E-Pharmacies. INTI Journal. 2022;2022.
61. Sharma D, Gupta S. The role of e-government in modern public health systems. Startup-Driven E-government: digital innovation for sustainable ecosystems: IGI Global Scientific Publishing; 2025. p. 239-72.
62. Pashkov V, Soloviov O, Harkusha A. Digital Marketing: Problems of Internet Pharmacies Legal Regulation. 2021.
63. Sakhare SA, Rajole RS, Bichewar PM, Sarkate RS, Shelke RR, Dhotre B, et al. Research on Pharmaceutical Sales and Marketing. International Journal of Sciences and Innovation Engineering. 2025;2(5):1150-72.
64. Limbu YB, Huhmann BA. Ethical issues in pharmaceutical marketing: A systematic review and future research agenda. Journal of Global Marketing. 2022;35(1):1-20.
65. Kooimans A. The persuasiveness of momfluencers in influencing dietary choices of first-time mothers. 2024.
66. Gibson S. Regulating direct-to-consumer advertising of prescription drugs in the digital age. Laws. 2014;3(3):410-38.
67. Anis MS. Assessment Of Digital Marketing Activities, Perception, Attitude, And Factors Impacting Purchasing Decision Of Over-The-Counter Drugs In A Malaysian Population 2022.
68. Proença MHD. The application of social media for marketing strategies in pharma healthcare: ISCTE-Instituto Universitario de Lisboa (Portugal); 2021.
69. AlShammari M, Assiri G, bin Buraykan M, Almogbel Y, Arafah A, Bashatah A, et al. The impact of direct-to-consumer pharmaceutical advertising on public knowledge of gastroesophageal reflux disease: a study on over-the-counter proton pump inhibitors. Patient preference and adherence. 2020:635-42.
70. Lawal O, Oyebamiji HO, Kelenna IJ, Chioma FJ, Oyefeso E, Adeyemi BI, et al. A review on usage of digital health literacy to combat antibiotic misuse and misinformation in Nigeria. Journal of Pharma Insights and Research. 2025;3(2):258-69.
71. Hollimon LA, Taylor KV, Fiegenbaum R, Carrasco M, Garchitorena Gomez L, Chung D, et al. Redefining and solving the digital divide and exclusion to improve healthcare: going beyond access to include availability, adequacy, acceptability, and affordability. Frontiers in Digital Health. 2025;7:1508686.
72. Barooah SP. Digital divide and access to medicines: the debate. Intellectual Property Law and Access to Medicines: Routledge; 2021. p. 464-82.
73. Hall J. Control of medicines. Pharmacy Practice E-Book: Pharmacy Practice E-Book. 2019:59.
74. Nielsen S, Van Hout MC. Over-the-counter codeine—from therapeutic use to dependence, and the grey areas in between. Non-medical and illicit use of psychoactive drugs: Springer; 2016. p. 59-75.
